Document is current
Any future updates will be listed below
-
Authors
Curhan, Sharon G. https://orcid.org/0000-0003-0282-0822
Glicksman, Jordan
Wang, Molin
Eavey, Roland D.
Curhan, Gary C.
-
Funding
Funding for this research was provided by:
National Institutes of Health (U01 DC010811)
National Institutes of Health (UO1 CA176726)
National Institutes of Health (R01 DC017717)
- License Information
-
More Information
Article History
Received: 13 August 2021
Accepted: 15 December 2021
First Online: 7 February 2022
Declarations
:
: Dr. S. Curhan serves as a consultant to Decibel Therapeutics. Dr. G. Curhan serves as a consultant to Decibel Therapeutics, AstraZeneca, Shire, RenalGuard, Allena Pharmaceuticals, OrfanBiotech, OM1, and Merck. He receives royalties from UpToDate for being an author and Section Editor. The other authors declare no conflicts of interest. All authors had access to the data and participated in the preparation of the manuscript.
Free to read: This content has been made available to all.
